ID
37719
Description
Study ID: 104864/517 Clinical Study ID: 104864/517 Study Title: A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00158886 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: Topotecan + Radiation therapy Trade Name: N/A Study Indication: Rectal Cancer, Carcinoma, Renal Cell
Mots-clés
Versions (1)
- 20/08/2019 20/08/2019 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
20 août 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Oral Topotecan as Radiosensitizing Agent in Patients with Rectal Cancer; NCT00158886
Adverse Experiences (Non-serious)
- StudyEvent: ODM
Description
Adverse Experiences (Non-serious)
Alias
- UMLS CUI-1
- C1518404
Description
Non-serious Adverse Event
Type de données
boolean
Alias
- UMLS CUI [1]
- C1518404
Description
Non-serious Adverse Event
Type de données
text
Alias
- UMLS CUI [1]
- C1518404
Description
Non-serious Adverse Event, Start Date, Start time
Type de données
datetime
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C0808070
- UMLS CUI [1,3]
- C1301880
Description
Non-serious Adverse Event, End Date, End time
Type de données
datetime
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C0806020
- UMLS CUI [1,3]
- C1522314
Description
Non-serious Adverse Event, Adverse Event Outcome
Type de données
text
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C1705586
Description
Non-serious Adverse Event, Course
Type de données
text
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C0750729
Description
Non-Serious Adverse Event, Episode, Numbers
Type de données
text
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C0332189
- UMLS CUI [1,3]
- C0237753
Description
Non-Serious Adverse Event, Toxicity Grade
Type de données
text
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C2826262
Description
Non-Serious Adverse Event, Adverse Event Action Taken with Study Treatment
Type de données
text
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C2826626
Description
Non-serious Adverse Event, Relationships, Experimental drug
Type de données
text
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C0439849
- UMLS CUI [1,3]
- C0304229
Description
Non-serious Adverse Event, Therapeutic procedure
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C0087111
Description
Non-serious Adverse Event, Withdraw
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C2349954
Similar models
Adverse Experiences (Non-serious)
- StudyEvent: ODM
C1300638 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,3])
C0806020 (UMLS CUI [1,2])
C1522314 (UMLS CUI [1,3])
C1705586 (UMLS CUI [1,2])
C0750729 (UMLS CUI [1,2])
C0332189 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,3])
C2826262 (UMLS CUI [1,2])
C2826626 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,2])
C2349954 (UMLS CUI [1,2])